Diabetes mellitus (DM) has been identified as an independent
|
|
- Blaze Elwin York
- 5 years ago
- Views:
Transcription
1 Diabetes Does Not Affect Long-Term Results After Total Arterial Off-Pump Coronary Revascularization Ho Young Hwang, MD, Jae-Sung Choi, MD, PhD, and Ki-Bong Kim, MD, PhD Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul; and Dongguk University Hospital, Goyang, Korea Background. We evaluated the influence of diabetes mellitus (DM) on 5-year angiographic results and longterm clinical outcomes in patients who underwent total arterial off-pump coronary revascularization for multivessel coronary disease. Methods. Between January 1998 and July 2004, total arterial revascularization for multivessel coronary disease was performed in 558 patients; 247 patients were diabetic (DM group) and 311 were nondiabetic (NDM group). Follow-up duration was months. Longterm survival, cardiac deaths, and major advanced cardiovascular or cerebral events were studied. Effects of DM on early, 1-year, and 5-year graft patency rates were compared using the generalized linear mixed model. Results. No differences in operative mortality and morbidity were observed. Overall survival in the DM group was significantly lower (p 0.004), with 10-year survival rates of 78.5% (vs 88.1% in the NDM group). Independent risk factors for long-term survival included smoking, chronic renal failure, and preoperative left ventricular dysfunction, but not DM itself. No differences in freedom from cardiac death were found between the 2 groups (p 0.171). Freedom from reintervention and major adverse cardiovascular and cerebral events were also similar between the groups. Early, 1-year, and 5-year postoperative angiographic patency rates in the DM group were 98.2%, 95.3%, and 94.6%, respectively. Those of the NDM group were 98.6%, 94.7%, and 90.5%. Diabetes mellitus did not affect graft patency rates. Conclusions. Diabetes mellitus did not affect 5-year angiographic results, long-term survival, and clinical events in patients with multivessel coronary disease who underwent total arterial off-pump revascularization. (Ann Thorac Surg 2010;90:1180 6) 2010 by The Society of Thoracic Surgeons Diabetes mellitus (DM) has been identified as an independent risk factor for development of coronary atherosclerosis [1]. Adverse effects of DM on surgical outcomes in patients who underwent coronary artery bypass grafting (CABG) have been reported, although controversy exists [2 6]. Previous studies have indicated that the arterial conduit may have a positive impact on maintenance of its biologic integrity and improvement of surgical outcomes in diabetic patients [7 9]. With renewed interest in off-pump CABG (OPCAB) since the mid-1990s, some authors have found reduced surgical morbidity in diabetic patients undergoing OPCAB compared with conventional CABG, although survival advantages were controversial [10 12]. The aim of this study was to evaluate whether or not diabetes has an influence on 5-year graft patency and long-term clinical outcomes in patients with multivessel coronary disease who underwent total arterial revascularization without the use of cardiopulmonary bypass. Material and Methods Accepted for publication May 10, Address correspondence to Dr Kim, Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, 28 Yeongeon-dong, Jongno-gu, Seoul , Korea; address : kimkb@snu.ac.kr. The study protocol was reviewed by the Institutional Review Board and approved as a minimal risk retrospective study (Approval Number: H ) that did not require individual consent based on the institutional guidelines for waiving consent. Patient Characteristics Between January 1998 and July 2004, 738 patients underwent isolated OPCAB in our institution. Among these, 558 (75.6%; male to female 419:139) patients with multivessel coronary disease who underwent total arterial OPCAB were enrolled in this study. Patients with single-vessel disease or patients who underwent OPCAB using saphenous vein grafting were excluded. Two hundred thirty six patients who had been previously diagnosed as diabetic and requiring pharmacologic glycemic control were included in the diabetic group. Eleven patients without a previous diagnosis of DM but with elevated glucose levels at admission (fasting glucose level 126 mg/dl; 2-hour glucose level after a meal during glucose tolerance test 200 mg/dl) were also included in the diabetic group (DM group; n 247). One hundred seventy one patients required oral drugs and 76 patients were treated with insulin therapy. Three hundred eleven patients were nondiabetic (NDM group). Preoperative characteristics were similar, except that there were more patients with left ventricular dysfunction, chronic renal failure, and peripheral vascular obstructive disease in the DM group (Table 1) by The Society of Thoracic Surgeons /$36.00 Published by Elsevier Inc doi: /j.athoracsur
2 Ann Thorac Surg HWANG ET AL 2010;90: EFFECT OF DM ON TOTAL ARTERIAL OPCAB 1181 Table 1. Patient Characteristics Variables Total (n 558) DM group (n 247) NDM group (n 311) p Age (years) Male/Female 419: :69 241: Unstable/stable angina 442: :52 245: Risk factors, n (%) Smoking 253 (45%) 102 (41%) 151 (49%) Hypertension 351 (63%) 163 (66%) 188 (61%) Overweight (BMI 25 kg/m 2 ) 238 (43%) 100 (41%) 138 (44%) Dyslipidemia 150 (27%) 66 (27%) 84 (27%) History of stroke 70 (13%) 36 (15%) 34 (11%) Chronic renal failure 33 (6%) 27 (11%) 6 (2%) LV dysfunction (EF 0.35) 34 (6%) 21 (9%) 13 (4%) PVOD 83 (15%) 48 (19%) 35 (11%) Three-vessel disease 392 (70%) 180 (73%) 212 (68%) Left main disease 182 (33%) 71 (29%) 111 (36%) BMI body mass index; DM diabetes mellitus; EF ejection fraction; LV left ventricle; NDM nondiabetic; PVOD peripheral vascular obstructive disease. Operative Strategy Basic principles and surgical procedures for OPCAB have been previously described [13]. A left internal thoracic artery (ITA) graft was used in almost all patients (n 556, 99.6%). Other arterial conduits included the right ITA (n 441), right gastroepiploic artery (n 346), and radial artery (n 9). All patients refrained from aspirin therapy (300 mg/day) on the day before surgery, and resumed it 1 day postoperatively. Bilateral ITAs were used more frequently in the NDM group (DM vs NDM, 74.1% vs 82.3%; p 0.018). Right gastroepiploic arteries were used more frequently in the DM group (70.0% vs 55.6%; p 0.001). Radial arteries were seldom used in either group (n 9, 1.6%). There were no differences between the groups in the number of distal anastomoses (DM vs NDM, vs ; p 0.508). Perioperative Management of Diabetes Mellitus Mixtures of intravenous insulin, glucose, and potassium (GIK regimen) were administered before surgery for all previously diagnosed patients with DM. The starting solution usually included 7 units of insulin in 500 ml of 5% dextrose containing 15 meq potassium and was infused at a rate of 80 ml/hour. The target glucose level ranged from 90 to 150 mg/dl, and the serum potassium level was maintained between 4.0 and 5.5 mmol/l. Blood glucose level was monitored hourly during the intraoperative and immediate postoperative periods. Infusion was stopped and the preoperative glucose control regimen was resumed once oral intake was established, usually on the first postoperative day. Evaluation of Long-Term Clinical Outcomes Patients underwent regular postoperative follow-up through the outpatient clinic at 3 or 4 month intervals, and were contacted by telephone for confirmation of their condition if the last clinic visit was not conducted at the scheduled time. Clinical and angiographic follow-up was completed on August 31, Follow-up was complete in 96.5% (530 of 549) of survivors, with a follow-up duration of months. Operative mortality was defined as death within 30 days. Cardiac death was defined as any death related to cardiac events, including sudden death during follow-up. Major adverse cardiovascular or cerebral events (MACCE) included acute myocardial infarction, coronary reintervention, death from any cause, and cerebrovascular accident. Evaluation of Angiographic Patency Early, 1-year, and 5-year follow-up coronary angiograms were performed regardless of patients angina symptoms. Patients who died, refused angiographic evaluation, or had renal function impairment were excluded from angiographic follow-up. However, patients with renal replacement therapy were included in angiographic follow-up. Early postoperative angiograms for evaluation of the anastomotic sites and patency of the grafts were performed in 97.1% (542 of 558) of all patients on postoperative days. One-year ( months) and 5-year ( months) angiograms were performed in 94.8% (499 of 526) and 80.1% (375 of 468) of all patients who were followed up for more than 1 year and 5 years, respectively. All 375 patients who underwent 5-year follow-up angiograms had both early and 1-year angiograms, and were enrolled for serial comparison of graft patency. More patients in the NDM group underwent follow-up angiograms (DM vs NDM; 74.0% [142 of 192] vs 84.4% [233 of 276]; p 0.005). One physician initially reviewed all coronary angiograms and consensus was reached after review. Graft patency was graded in the manner described by FitzGibbon and colleagues [14]. Steno-occlusion was defined as occluded or as stenosis of 75% of graft diameter or greater.
3 1182 HWANG ET AL Ann Thorac Surg EFFECT OF DM ON TOTAL ARTERIAL OPCAB 2010;90: Statistical Analysis Statistical analysis was performed using the SPSS software package (version 12.0; SPSS Inc, Chicago, IL) and SAS (version 9.1; Cary, NC). Data were expressed as mean standard deviation, median and ranges, or proportions. Comparison between the 2 groups was performed with the 2 test or Fisher exact test for categoric variables and the Student t test for continuous variables. Survival rates were estimated using the Kaplan-Meier method and comparisons between groups were performed using the log-rank test or Cox regression model. The Cox proportional hazard model was adopted for analysis of risk factors for overall late mortality and late cardiac death. Univariate variables with p values less than 0.05 were entered into the analysis. The generalized linear mixed model was adopted for analysis of the effects of DM, graft type, and revascularized territory on graft patency rates. To correct baseline differences, the propensity score of having diabetes was adjusted in the model. Underlying characteristics considered in estimation of propensity scores were the following: (1) age; (2) gender; (3) smoking status; (4) presence of obesity (body mass index 25 kg/m 2 ); (5) hypertension; (6) dyslipidemia; (7) chronic renal failure; (8) left ventricular dysfunction; (9) acute myocardial infarction; (10) left main coronary artery disease; (11) 3-vessel disease; (12) history of percutaneous coronary intervention; (13) emergent surgery; and (14) peripheral vascular obstructive disease. Kaplan-Meier curves were drawn using Prism software (version 5.0; GraphPad Software Inc, La Jolla, CA). A p value of less than 0.05 was considered statistically significant. Results Early Clinical Results Operative mortalities were 2.0% (5 of 247) in the DM group and 1.6% (5 of 311) in the NDM group (p 0.756). Early clinical outcomes including atrial fibrillation, perioperative myocardial infarction, mediastinitis, and cerebrovascular accident were similar between the 2 groups (Table 2). Fig 1. Overall survival of patients with and without diabetes mellitus. (DM diabetes mellitus group; NDM nondiabetes mellitus group.) Long-Term Survival Among 548 survivors, late death occurred in 72 (13.1%) patients, including 20 cardiac deaths. Overall survival rate was lower in the DM group than in the NDM group, with 10-year survival rates of 78.5% and 88.1%, respectively (p 0.004; Fig 1). Age-adjusted survival was also lower in the DM group (p 0.006). The survival rate for patients with insulin-treated DM was not significantly different from those with non-insulin treated DM (p 0.919). Multivariate analysis revealed that after age adjustment, smoking history, chronic renal failure, and preoperative left ventricular dysfunction, but not DM itself, were independent risk factors for long-term survival (Table 3). However, there were no significant differences in the incidence of late cardiac death between the groups, with 10-year freedom from cardiac death rates of 94.6% and 96.6%, respectively (DM vs NDM, p 0.109; Fig 2). Similar results were observed between patients with insulin-treated DM and those with non insulin-treated DM (p 0.836). Chronic renal failure and left ventricular dysfunction were significant risk factors Table 2. Early Mortality and Morbidities Variable Total (n 558) DM group (n 247) NDM group (n 311) p Mortality 10 (1.8%) 5 (2.0%) 5 (1.6%) Morbidities Atrial fibrillation 112 (20.1%) 56 (22.7%) 56 (18%) Perioperative myocardial infarction 32 (5.7%) 8 (3.2%) 20 (6.4%) Bleeding reoperation 22 (3.9%) 9 (3.6%) 13 (4.2%) Acute renal failure 11 (2.0%) 6 (2.4%) 5 (1.6%) Mediastinitis 3 (0.5%) 3 (1.2%) 0 (0%) Low cardiac output syndrome 1 (0.2%) 0 (0%) 1 (0.3%) Stroke 1 (0.2%) 0 (0%) 1 (0.3%) DM diabetes mellitus; NDM nondiabetic.
4 Ann Thorac Surg HWANG ET AL 2010;90: EFFECT OF DM ON TOTAL ARTERIAL OPCAB 1183 Table 3. Independent Predictors of Late Mortality Univariate Multivariate Variable p p Hazard Ratio [95% CI] Age Diabetes mellitus [ ] Chronic renal failure [ ] Smoking [ ] LV dysfunction [ ] PVOD [ ] BMI 25 kg/m [ ] Hypertension Dyslipidemia Female gender Left main disease Three-vessel disease Previous PCI Emergency BMI body mass index; CI confidence interval; LV left ventricular; PCI percutaneous coronary intervention; PVOD peripheral vascular obstructive disease. for age-adjusted long-term cardiac deaths (p 0.001, hazard ratio 6.67 and p 0.004, hazard ratio 2.66, respectively). Freedom From Reintervention and MACCE Sixty eight patients underwent coronary reintervention including 3 reoperations at months after surgery. Reintervention-free survival was similar between the 2 groups, with 10-year freedom from reintervention rates of 86.4% and 84.0%, respectively (DM vs NDM, p 0.509; Fig 3). A trend toward higher reintervention rates beyond 5 years after surgery was observed in the insulin-treated DM group, but it was not statistically significant (p Fig 3. Reintervention-free survival in patients with and without diabetes. (DM diabetes mellitus group; NDM nondiabetes mellitus group.) 0.173; Fig 4). There were no differences in freedom from MACCE at 10 years between the DM and NDM groups (66.2% vs 71.9%, p 0.111; Fig 5) and between the insulin-treated DM and noninsulin-treated DM groups (62.4% vs 67.6%, p 0.324). Early, 1-year, and 5-year Angiographic Patency In the DM group, early, 1-year, and 5-year postoperative patency rates were 98.2% (724 of 737), 95.3% (609 of 639), and 94.6% (417 of 441), respectively. Patency rates of the NDM group were 98.6% (899 of 912), 94.7% (826 of 872), and 90.5% (628 of 694). Analysis of patency rates according to graft type showed that patency rates of left ITA grafts at early, 1 year, and 5 years postoperatively were 99.2%, 95.8%, and 93.0%, respectively. Patency rates of right ITA grafts were 99.5%, 97.1%, and 93.2% and those of right gastroepiploic artery grafts were 98.8%, 92.9%, Fig 2. Late cardiac deaths in patients with and without diabetes. (DM diabetes mellitus group; NDM nondiabetes mellitus group.) Fig 4. Comparison of freedom from reintervention in diabetic patients according to insulin requirement. (DM diabetes mellitus group; NDM nondiabetes mellitus group.)
5 1184 HWANG ET AL Ann Thorac Surg EFFECT OF DM ON TOTAL ARTERIAL OPCAB 2010;90: Fig 5. Freedom from major adverse cardiovascular or cerebral events (MACCE) in diabetes mellitus (DM) and nondiabetes mellitus (NDM) groups. and 88.3%, respectively (Table 4). The generalized linear mixed model revealed that the presence of DM and type of arterial conduit did not affect patency rates in any of the 3 time periods. Patency rates of grafts anastomosed to the left anterior descending territory were higher than those connected to the left circumflex and right coronary artery territories at 1 year and 5 years after OPCAB (Table 5). Comment The present study demonstrated four important findings. First, not DM, but chronic renal failure and left ventricular dysfunction showed a negative impact on long-term survival in patients who underwent OPCAB with total arterial grafting. Second, freedom from cardiac death was similar between diabetic and nondiabetic patients. Third, freedom from MACCE, including reintervention, was similar, regardless of diabetic status. Fourth, DM did not influence the early, 1-year, and 5-year postoperative angiographic patency rates of the grafts. Previous studies have demonstrated poor early or late clinical outcomes, including mortality and freedom from reintervention in patients with DM who underwent CABG compared with those without DM [2 5]. However, controversy still exists [15, 16]. Since the renewal of interest in OPCAB in the mid-1990s, some authors have reported reduced surgical morbidity in diabetic patients undergoing OPCAB compared with conventional CABG, although they failed to demonstrate any survival advantage [10 12]. Previous studies have indicated that the arterial conduit might have a positive impact on maintenance of its biologic integrity and improvement of surgical outcomes in diabetic patients [7 9]. Anatomic patterns of coronary artery disease in DM patients are more complicated. Patients with DM frequently have left main or multivessel coronary disease. Lesions are more diffuse and luminal diameters are small in segments adjacent to obstructive lesions [17 19]. In order to control this bias, we only enrolled patients with multivessel coronary Table 4. Angiographic Patency Rates According to Graft Types and Revascularized Territories in the DM and NDM Groups Graft Territory Group No. of Anastomoses Early 1 Year 5 Years Left ITA Total % 95.8% 93.0% DM % 97.7% 96.0% NDM % 94.6% 91.3% Right ITA Total % 97.1% 93.2% DM % 98.1% 96.8% NDM % 96.5% 91.0% RGEA Total % 92.9% 88.3% DM % 93.6% 89.0% NDM % 92.4% 87.8% Radial artery Total % 88.9% 88.9% DM 0 NDM % 88.9% 88.9% LAD Total % 97.6% 95.5% DM % 98.6% 97.6% NDM % 96.9% 94.1% LCX Total % 95.1% 90.4% DM % 96.5% 93.7% NDM % 94.3% 88.5% RCA Total % 91.7% 86.7% DM % 93.3% 88.8% NDM % 90.7% 85.3% DM diabetes mellitus; ITA internal thoracic artery; LAD left anterior descending artery; LCX left circumflex artery; NDM nondiabetic; RCA right coronary artery; RGEA right gastroepiploic artery.
6 Ann Thorac Surg HWANG ET AL 2010;90: EFFECT OF DM ON TOTAL ARTERIAL OPCAB 1185 Table 5. Effects of Diabetes, Use of Grafts Other Than the Left ITA, and Revascularized Territories Other Than the LAD Territory on Graft Patency at Early, 1 Year, and 5 Years After Surgery Early 1 Year 5 Year Variable OR [95% CI] p OR [95% CI] p OR [95% CI] p DM a 2.03 [ ] [ ] [ ] Right ITA b 2.86 [ ] [ ] [ ] RGEA b 2.81 [ ] [ ] [ ] RA b 0.42 [ ] [ ] LCX c 2.36 [ ] [ ] [ ] RCA c 0.19 [ ] [ ] [ ] a Odds ratio of graft patency in the DM group compared to the NDM group; b Odds ratio of graft patency of right ITA or RGEA grafts compared to reference grafts (left ITA); c Odds ratio of patency of grafts anastomosed to the LCX or RCA territory compared with those anastomosed to the LAD territory. CI confidence interval; DM diabetes mellitus; ITA internal thoracic artery; LAD left anterior descending artery; LCX left circumflex artery; OR odds ratio; RA radial artery; RCA right coronary artery; RGEA right gastroepiploic artery. disease; proportions of patients with three-vessel coronary disease and left main coronary disease were similar between the 2 groups. This may have resulted in a somewhat higher incidence of diabetes in the present study than that of previous reports, which ranged from 14% to 30% [2 5]. Our treatment strategies for CABG include routine off-pump revascularization for most of our patients, exclusive use of total arterial graft with skeletonization, particularly in patients with diabetes or in younger patients. In our early experience, we avoided use of bilateral ITA grafts in DM patients out of concern for possible mediastinal infection, although it was controversial [20]. This explained the reason for more frequent use of bilateral ITA grafts in the NDM group when compared with the DM group. As demonstrated in the previous study [15], DM did not affect early clinical outcomes. Early mortality and postoperative complications, including atrial fibrillation, perioperative myocardial infarction, mediastinitis, and cerebrovascular accident were similar between the 2 groups. Overall longterm survival rate was lower in the DM group, with 10-year survival rates of 78.5% compared with 88.1% in the NDM group. Multivariate analysis revealed that it was not DM itself, but rather chronic renal failure, preoperative left ventricular dysfunction, and smoking that were independent risk factors for age-adjusted longterm survival. This was in agreement with other reports [3, 21] demonstrating that comorbidities of DM, such as chronic renal failure, peripheral vascular obstructive disease, and low left ventricular ejection fraction were independent risk factors for long-term survival. In addition, freedom from cardiac death was similar between the DM and NDM groups, and between patients with insulin-treated DM and those taking oral drugs. Again, chronic renal failure and left ventricular dysfunction were significant risk factors for late cardiac death. A previous study documented lower freedom from percutaneous intervention rates in DM patients, with a 10-year reintervention-free survival rate of 83% compared with 86% in non-dm patients [2]. However, a randomized controlled trial [22] revealed a similar 7-year freedom from reintervention rate in the DM group and the non-dm group (87.8% vs 88.9%). The present study showed an 86.4% reintervention-free survival rate at 10 years in the DM group and this was not statistically different from that of the NDM group. In addition, freedom from MACCE was not different between the 2 groups. Few studies have compared long-term angiographic patency of bypass grafts between patients with DM and those without DM who underwent CABG. In the Bypass Angioplasty Revascularization Investigation trial [23], graft patency assessed with angiograms performed 4 years after CABG showed that the percentages of ITA grafts (89% vs 85%) and vein grafts (71% vs 75%) free of stenosis were similar between patients with and without DM. In their study, however, only 37% of the patient population underwent follow-up angiograms. Since we began performing OPCAB at our institution in 1998, we have performed early postoperative graft angiography in almost all of our OPCAB patients to assess the accuracy of the anastomosis and graft patency. In addition, 1-year and 5-year follow-up coronary angiograms were performed regardless of patients angina symptoms. We evaluated graft patency at 5 years after surgery in 80.1% of patients followed up for more than 5 years. Baseline characteristics in patients with diabetes were different from those without DM. In addition, fewer patients in the DM group underwent 5-year angiograms than in the NDM group. This may have affected the results as a selection bias and the high angiographic patency rates demonstrated in the DM group. To correct these biases, the propensity score of having diabetes was adjusted in the generalized linear mixed model. The present study demonstrated that diabetes did not affect early and 1-year angiographic patency (p and 0.252). The UK prospective diabetes study [24] demonstrated that strict control of glycemia reduced microvascular complications and acute cardiac events. In addition, the Post Coronary Artery Bypass Graft Trial [25] reported that aggressive reduction of plasma lipids significantly reduced ischemic complications and improved permeability of aortocoronary grafts. The favorable angiographic results in the present study might be due to the fact that we strictly controlled glucose and lipid levels in all DM patients
7 1186 HWANG ET AL Ann Thorac Surg EFFECT OF DM ON TOTAL ARTERIAL OPCAB 2010;90: beginning in the immediate postoperative period. Preoperative comorbidities such as chronic renal failure or left ventricular dysfunction, not DM itself, were found to influence long-term survival and cardiac-related death in patients with multivessel disease treated with total arterial OPCAB. Freedom from MACCE, including coronary reintervention, was also similar between the DM and NDM groups. Medically controlled diabetes did not have negative effects on early, 1-year, and 5-year angiographic patency rates. There are limitations to the present study that must be recognized. First, the present study was not performed in a prospective manner, although all consecutive patients with multivessel disease who underwent OPCAB using total arterial grafts were included. There were some baseline differences between the 2 groups and these might have affected the results, although multivariate analysis and adjustment of the propensity score were performed to minimize this bias. Second, some of the patients treated with oral hypoglycemic agents at the time of surgery started insulin therapy during the follow-up period and some patients were diagnosed as new onset diabetes during admission for surgery. These were not evaluated in this study and this could have affected the clinical and angiographic comparison between groups. Measurement of hemoglobin A1 c level, one of the predicting factors for postoperative adverse outcomes in diabetic patients undergoing cardiac operations, was not performed preoperatively on all patients and was not included in the risk factor analysis. Finally, we did not compare these results with those of on-pump CABG or those of CABG using saphenous vein grafts. We wish to thank Professor Yun Hee Choi and Hyun-Sook Hong of the Medical Research Collaborating Center (MRCC), Seoul National University Hospital, for their efforts in statistical assistance. References 1. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 1979;59: Thourani VH, Weintraub S, Stein B, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999;67: Leavitt BJ, Sheppard L, Maloney C, et al. Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation 2004;110(11 Suppl I):II Alserius T, Hammar N, Nordqvist T, Ivert T. Improved survival after coronary artery bypass grafting has not influenced the mortality disadvantage in patients with diabetes mellitus. J Thorac Cardiovasc Surg 2009;138: Rajakaruna C, Rogers CA, Suranimala C, Angelini GD, Ascione, R. The effect of diabetes mellitus on patients undergoing coronary surgery: A risk-adjusted analysis. J Thorac Cardiovasc Surg 2006;123: Sahakyan K, Abramson JL, Krumholz HM, Vaccarino V. Comparison of functional status after coronary artery bypass grafting in patients with and without diabetes mellitus. Am J Cardiol 2006;98: Hirotani T, Kameda T, Kumamoto K, Shirota S, Yamano M. Effects of coronary artery bypass grafting using internal mammary arteries for diabetic patients. J Am Coll Cardiol 1999;34: Lorusso R, Pentiricci S, Raddino R, et al. Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. Diabetes 2003:52; Stevens LM, Carrier M, Perrault LP, et al. Influence of diabetes and bilateral internal thoracic artery grafts on long-term outcome for multivessel coronary artery bypass grafting. Eur J Cardiothorac Surg 2005;27: Magee MJ, Dewey TM, Acuff T, et al. Influence of diabetes on mortality and morbidity: off-pump coronary artery bypass grafting versus coronary artery bypass grafting with cardiopulmonary bypass. Ann Thorac Surg 2001;72: Srinivasan AK, Grayson AD, Fabri BM. On-pump versus off-pump coronary artery bypass grafting in diabetic patients: a propensity score analysis. Ann Thorac Surg 2004;78: Marcheix B, Eynden FV, Demers P, Bouchard D, Cariter R. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery. Ann Thorac Surg 2008;86: Kim K-B, Kang CH, Chang WI, et al. Off-pump coronary artery bypass with complete avoidance of aortic manipulation. Ann Thorac Surg 2002;74:S FitzGibbon GM, Burton JR, Leach AJ. Coronary bypass graft fate: angiographic grading of 1,400 consecutive grafts early after operation and of 1,132 after one year. Circulation 1978;57: Choi J-S, Cho KR, Kim K-B. Does diabetes affect the postoperative outcomes after total arterial off-pump coronary bypass surgery in multivessel disease? Ann Thorac Surg 2005;80: Calafiore AM, Di Mauro M, Di Giammarco G, et al. Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg 2003;125: Waller BF, Palumbo PJ, Lie JT, Roberts WC. Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years: analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am J Med 1980;69: Burchfiel CM, Reed DM, Marcus EB, Strong JP, Hayashi T. Association of diabetes mellitus with coronary atherosclerosis and myocardial lesions: an autopsy study from the Honolulu Heart Program. Am J Epidemiol 1993;137: Goraya TY, Leibson CL, Palumbo PJ, et al. Coronary atherosclerosis in diabetes mellitus: a population based autopsy study. J Am Coll Cardiol 2002;40: Matsa M, Paz Y, Gurevitch J, et al. Bilateral skeletonized internal thoracic artery grafts in patients with diabetes mellitus. J Thorac Cardiovasc Surg 2001;121: Mohammadi S, Dagenais F, Mathieu P, et al. Long-term impact of diabetes and its comorbidities in patients undergoing isolated primary coronary artery bypass graft surgery. Circulation 2007;116(11 suppl):i Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000;35: Schwartz L, Kimp KE, Frye RL, Alderman EL, Schaff HV, Detre KM. Coronary bypass graft patency in patients with diabetes in the bypass angioplasty revascularization investigation (BARI). Circulation 2002;106: Turner RC, Holman RR, Cull CA, Stratton IM. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352: Hoogwerf BJ, Waness A, Cressman M, et al. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes 1999;48:
Importance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationLeft Subclavian Artery Stenosis in Coronary Artery Bypass: Prevalence and Revascularization Strategies
Left Subclavian Artery Stenosis in Coronary Artery Bypass: Prevalence and Revascularization Strategies Ho Young Hwang, MD, Jin Hyun Kim, MD, Whal Lee, MD, PhD, Jae Hyung Park, MD, PhD, and Ki-Bong Kim,
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationCoronary atherosclerotic heart disease remains the number
Twenty-Year Survival After Coronary Artery Surgery An Institutional Perspective From Emory University William S. Weintraub, MD; Stephen D. Clements, Jr, MD; L. Van-Thomas Crisco, MD; Robert A. Guyton,
More informationThe Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting
Original Article The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting Toshihiro Fukui, MD, Susumu Manabe, MD, Tomoki Shimokawa, MD,
More informationJournal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL
More informationSurgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome
Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Chris C. Cook, MD Associate Professor of Surgery Director, CT Residency Program, WVU ACOI 10/17/18 No Disclosures
More informationSURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS?
SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS? Luigi Martinelli Chief, Dept. of Surgery Istituto Clinico Ligure di Alta Specialità RAPALLO During 1987 2006,
More informationIncidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction
Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction Sungmin Lim, Yoon Seok Koh, Hee Yeol Kim, Ik Jun Choi, Eun Ho Choo, Jin Jin Kim, Mineok
More informationThe Second Best Arterial Graft:
The Second Best Arterial Graft: A Propensity Analysis of the Radial Artery Versus the Right Internal Thoracic Artery to Bypass the Circumflex Coronary Artery American Association for Thoracic Surgery,
More informationImproved long-term survival has been demonstrated by
Benefit of Bilateral Over Single Internal Mammary Artery Grafts for Multiple Coronary Artery Bypass Grafting Masahiro Endo, MD; Hiroshi Nishida, MD; Yasuko Tomizawa, MD; Hiroshi Kasanuki, MD Background
More informationThe most important advantage of CABG over PTCA is its
Coronary Artery Bypass With Only In Situ Bilateral Internal Thoracic Arteries and Right Gastroepiploic Artery Hiroshi Nishida, MD; Yasuko Tomizawa, MD; Masahiro Endo, MD; Hitoshi Koyanagi, MD; Hiroshi
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationUnprotected LM intervention
Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline
More informationReoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes
Original Article Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes AR Jodati, MA Yousefnia From Department of Cardiothoracic Surgery, Madani Heart Hospital, Tabriz University
More informationCoronary artery bypass grafting (CABG) is a temporary treatment for a
Surgery for Acquired Cardiovascular Disease Influence of patient characteristics and arterial grafts on freedom from coronary reoperation Joseph F. Sabik III, MD, a Eugene H. Blackstone, MD, a,b A. Marc
More informationRelationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome
Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João
More informationOn-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery
On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict
More informationWhat is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?
What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? Keun-Ho Park, Myung Ho Jeong, Min Goo Lee, Jum Suk Ko,
More informationOff-Pump Bilateral Internal Thoracic Artery Grafting in Right Internal Thoracic Artery to Right Coronary System
Off-Pump Bilateral Internal Thoracic Artery Grafting in Right Internal Thoracic Artery to Right Coronary System ADULT CARDIAC Hyun-Chel Joo, MD, Young-Nam Youn, MD, PhD, Gijong Yi, MD, PhD, Byung-Chul
More informationCoronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid?
Coronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid? Dr. Daniel Navia M.D. Chief Cardiac Surgery Department ICBA, Buenos Aires Argentina, 2018 No disclosures 2 Current evidence The FREEDOM
More informationCan Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!
Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Young-Hak Kim, MD, PhD Heart Institute, University of Ulsan College of Medicine Asan Medical Center,
More informationImproved Functional Mitral Regurgitation After Off-Pump Revascularization in Acute Coronary Syndrome
Improved Functional Mitral Regurgitation After Off-Pump Revascularization in Acute Coronary Syndrome Ho Young Hwang, MD, PhD, Jae Hong Lim, MD, Se Jin Oh, MD, Jin Chul Paeng, MD, PhD, and Ki-Bong Kim,
More informationComparison of Coronary Artery Bypass Grafting With Drug-Eluting Stent Implantation for the Treatment of Multivessel Coronary Artery Disease
Comparison of Coronary Artery Bypass Grafting With Drug-Eluting Stent Implantation for the Treatment of Multivessel Coronary Artery Disease Jeong Hoon Yang, MD, Hyeon-Cheol Gwon, MD, Soo Jin Cho, MD, Joo
More informationDrug-eluting stents (DESs) show a lower incidence of
ADULT CARDIAC Comparison of Off-pump Coronary Artery Bypass Grafting With Percutaneous Coronary Intervention Versus Drug-Eluting Stents for Three-Vessel Coronary Artery Disease Gijong Yi, MD, Young-Nam
More informationThe MAIN-COMPARE Registry
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationOff-Pump Coronary Artery Bypass Grafting With Skeletonized Bilateral Internal Thoracic Arteries in Insulin-Dependent Diabetics
Off-Pump Coronary Artery Bypass Grafting With Skeletonized Bilateral Internal Thoracic Arteries in Insulin-Dependent Diabetics Masashi Kai, MD, Michiya Hanyu, MD, PhD, Yoshiharu Soga, MD, PhD, Takuya Nomoto,
More informationDeclaration of conflict of interest NONE
Declaration of conflict of interest NONE Claudio Muneretto MD, PhD Director of Division of Cardiac Surgery University of Brescia Medical School Italy Hybrid Chymera Different features and potential advantages
More informationCoronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy
Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy Takayuki Ohno, MD, Shinichi Takamoto, MD, Noboru Motomura, MD, Minoru Ono,
More informationPROMUS Element Experience In AMC
Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical
More informationPCI for Left Anterior Descending Artery Ostial Stenosis
PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationSetting The setting was a hospital. The economic study was carried out in Australia.
Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationUnprotected Left Main Coronary Artery Disease in Patients With Low Predictive Risk of Mortality
Unprotected Left Main Coronary Artery Disease in Patients With Low Predictive Risk of Mortality Shun Watanabe, MD, Tatsuhiko Komiya, MD, Genichi Sakaguchi, MD, PhD, and Takeshi Shimamoto, MD, PhD Department
More informationEffect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators
More informationAbstract Background: Methods: Results: Conclusions:
Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li
More informationSupplementary Table S1: Proportion of missing values presents in the original dataset
Supplementary Table S1: Proportion of missing values presents in the original dataset Variable Included (%) Missing (%) Age 89067 (100.0) 0 (0.0) Gender 89067 (100.0) 0 (0.0) Smoking status 80706 (90.6)
More informationDuring the last years, many reports have clearly
Single Versus Bilateral Internal Mammary Artery for Isolated First Myocardial Revascularization in Multivessel Disease: Long-Term Clinical Results in Medically Treated Diabetic Patients Antonio Maria Calafiore,
More informationWhat oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor
76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of
More informationCORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW
CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):
More informationThe use of both the left and right internal thoracic arteries (ITAs) for revascularization
Angiographic evidence for reduced graft patency due to competitive flow in composite arterial T-grafts Dmitry Pevni, MD, a Itzhak Hertz, MD, b Benjamin Medalion, MD, c Amir Kramer, MD, a Yosef Paz, MD,
More informationDiabetes has long been described as an independent
Effect of Risk-Adjusted Diabetes on Mortality and Morbidity After Coronary Artery Bypass Surgery Chandrasahekhar Kubal, MRCS, Arun K. Srinivasan, FRCS, Antony D. Grayson, BS, Brian M. Fabri, FRCS(Ed),
More informationChronic total occlusion occurs in 10% of patients with
Off-Pump Revascularization of Chronically Occluded Left Anterior Descending Artery Through Left Anterior Small Thoracotomy: Early and Late Angiographic and Clinical Follow-Up Gabriele Di Giammarco, MD,
More informationSurgery for Acquired Cardiovascular Disease
Surgery for Acquired Cardiovascular Disease Shah et al Factors affecting saphenous vein graft patency: Clinical and angiographic study in 1402 symptomatic patients operated on between 1977 and 1999 Pallav
More informationCONTEMPORARY USE OF ARTERIAL GRAFTS DURING CORONARY ARTERY BYPASS SURGERY: PARADIGM SHIFT? OR A LITTLE (MORE) TALK THAT NEEDS A LOT MORE ACTION
CONTEMPORARY USE OF ARTERIAL GRAFTS DURING CORONARY ARTERY BYPASS SURGERY: PARADIGM SHIFT? OR A LITTLE (MORE) TALK THAT NEEDS A LOT MORE ACTION JAMES L ZELLNER MD I have no financial disclosures. 1897
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total
More informationSafety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD
Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell
More informationAlex versus Xience Registry Preliminary report
Interventional Cardiology Network Alex versus Xience Preliminary report Mariusz Gąsior 1,2, Marek Gierlotka 1, Lech Poloński 1,2 1 3rd Department of Cardiology, Medical University of Silesia Centre tor
More informationResults of Reoperation
Results of Reoperation for Recurrent Angina Pectoris William I. Norwood, M.D., Lawrence H. Cohn, M.D., and John J. Collins, Jr., M.D. ABSTRACT Although a coronary bypass operation improves the quality
More informationTSDA ACGME Milestones
TSDA ACGME Milestones Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short
More informationLessons learned From The National PCI Registry
Lessons learned From The National PCI Registry w a v e On Behalf of The Publication Committee of the National PCI Registry Objectives & Anticipated Achievements To determine the epidemiology of patients
More informationThe radial artery is protective in women and men following coronary artery bypass grafting a substudy of the radial artery patency study
Featured Article The radial artery is protective in women and men following coronary artery bypass grafting a substudy of the radial artery patency study Derrick Y. Tam 1,2, Saswata Deb 1,2, Bao Nguyen
More informationSupplementary Material to Mayer et al. A comparative cohort study on personalised
Suppl. Table : Baseline characteristics of the patients. Characteristic Modified cohort Non-modified cohort P value (n=00) Age years 68. ±. 69.5 ±. 0. Female sex no. (%) 60 (0.0) 88 (.7) 0.0 Body Mass
More informationPCI vs. CABG From BARI to Syntax, Is The Game Over?
PCI vs. CABG From BARI to Syntax, Is The Game Over? Seung-Jung Park, MD, PhD Professor of Medicine, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea PCI vs CABG Multi-Vessel Disease
More informationPercutaneous Coronary Interventions Without On-site Cardiac Surgery
Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European
More informationManagement during Reoperation of Aortocoronary Saphenous Vein Grafts with Minimal Atherosclerosis by Angiography
Management during Reoperation of ortocoronary Saphenous Vein Grafts with therosclerosis by ngiography William G. Marshall, Jr., M.D., Jeffrey Saffitz, M.D., and Nicholas T. Kouchoukos, M.D. STRCT The proper
More informationInfluence of Planned Six-Month Follow-Up Angiography on Late Outcome After Percutaneous Coronary Intervention A Randomized Study
Journal of the American College of Cardiology Vol. 38, No. 4, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01476-0 Influence
More informationESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH
ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO
More informationJournal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary
More informationAortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction
Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction L.S.C. Czer, S. Goland, H.J. Soukiasian, S. Gallagher, M.A. De Robertis, J. Mirocha,
More informationIs bypass surgery needed for elderly patients with LMT disease? From the surgical point of view
CCT 2003 (Kobe) Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view Hitoshi Yaku, MD, PhD Department of Cardiovascular Surgery Kyoto Prefectural University of
More informationImplications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011
Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011 Prof. Dr. Volkmar Falk Klinik für Herz- und Gefäßchirurgie, Universitätsspital Zürich, Schweiz In 2004 headlines were
More informationDisclosures The PREVENT IV Trial was supported by Corgentech and Bristol-Myers Squibb
Saphenous Vein Grafts with Multiple Versus Single Distal Targets in Patients Undergoing Coronary Artery Bypass Surgery: One-Year Graft Failure and Five-Year Outcomes from the Project of Ex-vivo Vein Graft
More informationClinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease
Cronicon OPEN ACCESS EC NEUROLOGY Research Article Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Jin Ok Kim, Hyung-IL Kim, Jae Guk Kim, Hanna Choi, Sung-Yeon
More informationEarly and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris
Fukui et al Acquired Cardiovascular Disease Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui, MD, a
More informationSupplementary Online Content
1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing
More informationEarly Angiographic Results of Multivessel Off-Pump Coronary Artery Bypass Grafting
Original Article Early Angiographic Results of Multivessel Off-Pump Coronary Artery Bypass Grafting Mimiko Tabata, MD, Hiroshi Niinami, MD, PhD, Yuji Suda, MD, Akihito Sasaki, MD, Masato Yamamoto, MD,
More informationLeft Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage
Left Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage Shishir Karthik, FRCS, Arun K. Srinivasan, FRCS, Antony D. Grayson, BS, Mark
More informationImpact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease
Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Gjin Ndrepepa, Tomohisa Tada, Massimiliano Fusaro, Lamin King, Martin Hadamitzky,
More informationMandatory knowledge about natural history of coronary grafts. P.Sergeant P. Maureira K.U.Leuven, Belgium
Mandatory knowledge about natural history of coronary grafts P.Sergeant P. Maureira K.U.Leuven, Belgium Types of grafts Arterial ITA/IMA (internal thoracic/mammary artery) Radial artery Gastro-epiploïc
More informationDrug-Eluting Stents Versus Bilateral Internal Thoracic Grafting for Multivessel Coronary Disease
Drug-Eluting Stents Versus Bilateral Internal Thoracic Grafting for Multivessel Coronary Disease Itzhak Herz, MD, Yaron Moshkovitz, MD, Dan Loberman, MD, Gideon Uretzky, MD, Rony Braunstein, PhD, Alberto
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationPeriprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion
Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol
More informationSurgery for Acquired Cardiovascular Disease
Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery Rajendra H. Mehta, MD, MS, a Gail E. Hafley, MS,
More informationFFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium
FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium Conflict of Interest Institutional research grants and speaker s fee from St. Jude Medical and Boston Scientic to Cardiovascular
More informationDo Angiographic Results From Symptom-Directed Studies Reflect True Graft Patency?
CARDIOVASCULAR Do Angiographic Results From Symptom-Directed Studies Reflect True Graft Patency? Brian F. Buxton, FRACS, Manoj Durairaj, MCh, David L. Hare, FRACP, Ian Gordon, PhD, Simon Moten, FRACS,
More informationThe clinical and prognostic benefits of coronary artery bypass grafting (CABG)
ORIGINAL ARTICLE Total arterial myocardial revascularization: analysis of initial experience Shahzad Gull Raja, MRCS; Zulfiqar Haider, FRCS; Haider Zaman, FRCS (CTh); Mukhtar Ahmed, FRCS BACKGROUND: Total
More informationDiabetic Patients: Current Evidence of Revascularization
Diabetic Patients: Current Evidence of Revascularization Alexandra J. Lansky, MD Yale University School of Medicine University College of London The Problem with Diabetic Patients Endothelial dysfunction
More informationTrial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease (BEST Trial)
Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease (BEST Trial) Seung-Jung Park, MD, PhD On behalf of the BEST investigators Professor of Medicine, University of Ulsan College of
More informationAnalysis of Mortality Within the First Six Months After Coronary Reoperation
Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic
More informationRevascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing
Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing Evidence and Uncertainties Robert O. Bonow, MD, MS, MACC Northwestern University Feinberg School of Medicine
More informationMinimally invasive direct coronary artery bypass for left anterior descending artery revascularization analysis of 300 cases
Original paper Videosurgery Minimally invasive direct coronary artery bypass for left anterior descending artery revascularization analysis of 300 cases Lufeng Zhang, Zhongqi Cui, Zhiming Song, Hang Yang,
More informationOPCABG for Full Myocardial Revascularisation How we do it
OPCABG for Full Myocardial Revascularisation How we do it 28 th SHA Conferance Dr.Farouk Oueida Head of Cardiac Surgery Dept. SBCC-Dammam KSA The Less Invasive CABG Full Revascularisation Full Sternotomy
More informationAtrial Fibrillation Predicts Worse Long Time Prognosis after CABG A 6-Year Survival Analysis
Open Journal of Thoracic Surgery, 2012, 2, 18-22 http://dx.doi.org/10.4236/ojts.2012.22006 Published Online June 2012 (http://www.scirp.org/journal/ojts) Atrial Fibrillation Predicts Worse Long Time Prognosis
More informationComparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroscore
Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroscore Marzia Leacche, MD, John G. Byrne, MD, Natalia S. Solenkova,
More informationDECISION-CTO. Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion. Seung-Jung Park, MD., PhD.
DECISION-CTO Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion Seung-Jung Park, MD., PhD. Heart Institute, University of Ulsan College of Medicine Asan Medical Center,
More informationEarly results after myocardial revascularization without cardiopulmonary bypass
Cardiopulmonary Support and Physiology Calafiore et al Bilateral internal thoracic artery grafting with and without cardiopulmonary bypass: Six-year clinical outcome Antonio M. Calafiore, MD, a Gabriele
More informationMyocardial revascularization without cardiopulmonary
Multiple Arterial Conduits Without Cardiopulmonary Bypass: Early Angiographic Results Antonio M. Calafiore, MD, Giovanni Teodori, MD, Gabriele Di Giammarco, MD, Giuseppe Vitolla, MD, Nicola Maddestra,
More informationAngiographic 5-Year Follow-up Study of Right Gastroepiploic Artery Grafts
Angiographic 5-Year Follow-up Study of Right Gastroepiploic Artery Grafts Sari Voutilainen, MD, Kalervo Verkkala, MD, PhD, Antero J~irvinen, MD, PhD, and Pekka Keto, MD, PhD Departments of Thoracic and
More informationCulprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome
Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,
More informationDoes preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting?
Ad et al Acquired Cardiovascular Disease Does preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting? Niv Ad, MD, a Scott D. Barnett, PhD,
More informationBeta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes
Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National
More informationDaryoush Samim, Enrico Ferrari, MD, FETCS, PD&MER
On- pump versus off- pump coronary artery bypass grafting with left internal mammary artery for left anterior descending artery stenosis: a retrospective study over 15 years Daryoush Samim, Enrico Ferrari,
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationand Paul C. Taylor, M.D. ORIGINAL ARTICLES
ORIGINAL ARTICLES Trends in Selection and Results of Coronary Artery Reoperations Floyd D. Loop, M.D., Bruce W. Lytle, M.D., Carl C. Gill, M.D., Leonard A. R. Golding, M.D., Delos M. Cosgrove, M.D., and
More informationhigh SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin Turin / Italy
What to do with patients with high SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin San Giovanni Battista Hospital Turin / Italy Who are the patients with high SYNTAX
More informationMichael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX
Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX Maquet, Inc.,- unpaid consultant Cordis, Inc.,- unpaid consultant Boston Scientific, Inc.,- travel expenses paid for Syntax
More information